[1]
Mullokulov J., Akhmedov Kh., Anorboev M. 2025. HEAD-TO-HEAD COMPARATIVE EFFICACY OF GOLIMUMAB VS. TOFACITINIB IN REACTIVE ARTHRITIS: A 52-WEEK REAL-WORLD COHORT STUDY FROM UZBEKISTAN. Central Asian Journal of Medicine. 1, 10 (Dec. 2025), 58–64.